From: Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19
Characteristic | Total (n = 53) | Severe group (n = 37) | Critical group (n = 16) | Z value | P value |
---|---|---|---|---|---|
Lymphocyte classification | Â | Â | Â | Â | Â |
Lymphocyte, median (IQR), × 106/L | 659.00 (480.50–885.50) | 743.00 (517.00–965.50) | 547.00 (473.00–704.75) |  − 1.792 | 0.073 |
CD3+, median (IQR), × 106/L | 417.00 (252.50–571.50) | 430.00 (327.00–602.00) | 327.00 (211.75–476.75) |  − 1.482 | 0.138 |
CD4+, median (IQR), × 106/L | 261.00 (153.50–351.50) | 280.00 (173.00–380.50) | 211.00 (131.50–294.75) |  − 1.782 | 0.075 |
CD8+, median (IQR), × 106/L | 140.00 (95.00–205.00) | 148.00 (95.00–234.50) | 120.00 (90.75–160.25) |  − 1.298 | 0.194 |
CD19+, median (IQR), × 106/L | 109.00 (77.50–144.50) | 116.00 (86.00–146.00) | 99.00 (46.00–128.75) |  − 1.579 | 0.114 |
NK, median (IQR), × 106/L | 102.00 (65.50–166.00) | 103.00 (77.50–175.00) | 87.00 (49.50–133.50) |  − 1.298 | 0.194 |
CD3+, median (IQR),% | 62.59 (54.61–68.75) | 62.59 (56.71–68.28) | 61.37 (49.94–70.59) |  − 0.019 | 0.985 |
CD4+, median (IQR),% | 37.78 (29.18–43.56) | 38.54 (30.89–43.93) | 30.14 (26.93–40.06) |  − 1.376 | 0.169 |
CD8+, median (IQR),% | 22.42 (17.52–29.01) | 21.13 (17.32–27.49) | 22.86 (18.58–36.27) | 0.872 | 0.383 |
CD19+, median (IQR),% | 17.48 (13.29–22.21) | 17.00 (14.65–21.74) | 18.87 (11.86–22.82) |  − 0.194 | 0.846 |
NK, median (IQR),% | 18.64 (10.10–25.99) | 16.68 (12.29–25.77) | 19.39 (9.23–26.18) | 0.039 | 0.969 |
CD4+/CD8+, median (IQR) | 1.53 (1.12–2.43) | 1.82 (1.20–2.34) | 1.24 (0.84–2.55) |  − 1.066 | 0.287 |
Cytokine profiles | Â | Â | Â | Â | Â |
IL-4, median (IQR), pg/mL | 1.68 (1.26–2.45) | 1.55 (1.20–2.38) | 1.99 (1.32–2.50) | 1.027 | 0.304 |
IL-6, median (IQR), pg/mL | 18.08 (6.69–46.45) | 17.35 (6.69–43.62) | 21.89 (7.20–85.51) | 1.077 | 0.281 |
IL-10, median (IQR), pg/mL | 3.83 (2.98–5.16) | 3.55 (2.81–4.94) | 4.79 (3.23–6.25) | 1.705 | 0.088 |
IL-17, median (IQR), pg/mL | 1.18 (1.02–1.37) | 1.15 (1.00–1.33) | 1.20 (1.04–1.47) | 0.349 | 0.727 |
TNF-α, median (IQR), pg/mL | 3.05 (1.61–5.42) | 3.12 (1.36–5.59) | 2.93 (2.19–5.25) | 0.281 | 0.779 |
IFN-γ, median (IQR), pg/mL | 4.32 (2.32–8.72) | 5.18 (2.00–10.04) | 4.08 (2.35–7.44) | − 0.562 | 0.574 |